Trial Profile
Depakote [valproate semisodium] ER [extended release] vs seroquel [quetiapine] for agitated behaviors in nursing home care unit patients with dementia
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 01 Aug 2018
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Valproate semisodium
- Indications Dementia
- Focus Therapeutic Use
- 25 Apr 2017 Status changed from completed to discontinued.
- 31 Aug 2012 Actual end date (1 Mar 2008) added as reported by ClinicalTrials.gov record.
- 31 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.